CIK 0001711279 · Large accelerated filer
Krystal Biotech, Inc.
Sign in to watch- Ticker
- KRYS
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 821080209
- Phone
- (412) 586-5830
- Business address
- 2100 WHARTON STREET, SUITE 701, PITTSBURGH, PA, 15203
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $17,966,069
- in 2 filings, $18.0M under 10b5-1 plans
Net −$17,966,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-05-22 | Romano Kathryn Chief Accounting Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,500 | 12,500 | ||
| 2023-05-22 | Romano Kathryn Chief Accounting Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,500 | 37,500 | ||
| 2023-05-19 | Romano Kathryn Chief Accounting Officer | Option exercise 10b5-1 | +12,500 | $52.26 | $653K | 28,484 |
| 2023-05-19 | Romano Kathryn Chief Accounting Officer | Sale 10b5-1 | −12,500 | $95.05 | $1.2M | 15,984 |
| 2023-05-19 | Romano Kathryn Chief Accounting Officer | Option exercise 10b5-1 | +12,500 | $52.26 | $653K | 28,484 |
| 2023-05-19 | Romano Kathryn Chief Accounting Officer | Sale 10b5-1 | −12,500 | $95.04 | $1.2M | 15,984 |
| 2023-05-19 | Romano Kathryn Chief Accounting Officer | Sale 10b5-1 | −3,428 | $95.08 | $326K | 12,556 |
| 2023-05-19 | Romano Kathryn Chief Accounting Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,500 | 37,500 | ||
| 2023-05-19 | Romano Kathryn Chief Accounting Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −12,500 | 25,000 | ||
| 2023-05-19 | JANNEY DANIEL Director | Sale 10b5-1 | −50,000 | $95.02 | $4.8M | 157,362 |
| 2023-05-09 | JANNEY DANIEL Director | Sale 10b5-1 | −17,100 | $90.74 | $1.6M | 207,362 |
| 2023-04-19 | JANNEY DANIEL Director | Sale 10b5-1 | −7,900 | $90.32 | $713K | 224,462 |
| 2023-04-17 | Krishnan Suma President, R&D | Sale 10b5-1 | −1,050 | $85.55 | $90K | 1,673,156 |
| 2023-04-17 | Krishnan Suma President, R&D | Sale 10b5-1 | −4,297 | $86.80 | $373K | 1,668,859 |
| 2023-04-17 | Krishnan Suma President, R&D | Sale 10b5-1 | −9,429 | $87.41 | $824K | 1,659,430 |
| 2023-04-17 | Krishnan Suma President, R&D | Sale 10b5-1 | −9,724 | $88.41 | $860K | 1,649,706 |
| 2023-04-17 | Krishnan Suma President, R&D | Sale 10b5-1 | −500 | $89.12 | $45K | 1,649,206 |
| 2023-04-17 | Krishnan Suma President, R&D | Sale 10b5-1 | −1,050 | $85.55 | $90K | 1,737,638 |
| 2023-04-17 | Krishnan Suma President, R&D | Sale 10b5-1 | −4,298 | $86.80 | $373K | 1,733,340 |
| 2023-04-17 | Krishnan Suma President, R&D | Sale 10b5-1 | −9,428 | $87.41 | $824K | 1,723,912 |
Page 31 of 42 · 828 trades